Skip to content
The Nexus
HEALTHJul 20 · 11:00 UTCSCMP CHINAJulie Zhang

‘Systemic leap’: China’s drug innovation push yields bumper crop

In the first half of the year, over 80% of China's market drug approvals were domestically produced novel drugs, with 31 out of 38 total approvals. This reflects a 'leap' in pharmaceutical innovation, according to a government spokesman from the Ministry of Industry and Information Technology.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Tao QingpersonMinistry of Industry and Information TechnologyorganizationChinaplacepharmaceutical innovationtopicBeijingplace
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting